PortfoliosLab logoPortfoliosLab logo
ISIN
US3736785078
CUSIP
373678507
IPO Date
Apr 9, 1999

Highlights

EPS (TTM)
-$35.50
Total Revenue (TTM)
$3.35M
Gross Profit (TTM)
$3.30M
EBITDA (TTM)
-$25.24M
Year Range
$0.96 - $24.50
Target Price
$100.00
ROA (TTM)
-0.00%
ROE (TTM)
-0.00%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


GeoVax Labs, Inc.

Performance

GOVX Performance Chart

GeoVax Labs, Inc. (GOVX) is down 69.1% since the beginning of the year. At $1 per share, GOVX is trading 94.6% below its 52-week high of $25. Investors who bought $1,000 worth of GOVX shares 5 years ago would now be looking at an investment worth $1.


Loading charts...

S&P 500 Index

Returns By Period

GeoVax Labs, Inc. (GOVX) has returned -69.12% so far this year and -94.41% over the past 12 months. Over the last ten years, GOVX has returned -74.73% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


GeoVax Labs, Inc.

1D
-1.49%
1M
-63.74%
YTD
-69.12%
6M
-69.36%
1Y
-94.41%
3Y*
-81.91%
5Y*
-76.67%
10Y*
-74.73%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GOVX Monthly Returns History

Based on dividend-adjusted daily data since Jul 23, 2012, GOVX's average daily return is +6.82%, while the average monthly return is +62.73%. At this rate, an investment would double in approximately 0.1 years.

Historically, 29% of months were positive and 71% were negative. The best month was May 2019 with a return of +11,509.2%, while the worst month was Jul 2019 at -82.3%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.

On a daily basis, GOVX closed higher 36% of trading days. The best single day was May 2, 2019 with a return of +24,275.0%, while the worst single day was Jan 28, 2020 at -58.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-34.50%-42.86%-13.75%-21.01%88.99%-35.92%-69.12%
2025-22.67%-24.61%-26.39%-4.72%0.99%-15.13%-16.80%3.51%-36.55%19.57%-27.33%-58.40%-93.08%
2024-38.50%-23.12%-21.87%-29.99%29.99%75.00%-34.69%122.60%-47.95%-18.26%34.01%-6.44%-54.39%
202328.37%-16.89%-1.10%-7.02%0.27%-11.29%3.84%0.96%-10.86%-3.70%-13.43%-15.75%-42.72%
2022-33.15%-26.86%-35.03%-31.30%122.78%-52.84%228.88%-56.41%-8.40%-13.76%-15.55%-20.61%-82.59%
202138.46%8.97%-14.12%24.20%-0.37%-7.75%-12.60%39.36%-29.06%-3.24%-1.20%-12.35%7.10%

Benchmark Metrics

GeoVax Labs, Inc. has an annualized alpha of 1975092080.86%, beta of -1.33, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since July 23, 2012.

  • This stock participated in 236.81% of S&P 500 Index downside but only -126.77% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of -1.33 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
1,975,092,080.86%
Beta
-1.33
0.00
Upside Capture
-126.77%
Downside Capture
236.81%

Return for Risk

Risk / Return Rank

GOVX ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


GOVX Risk / Return Rank: 77
Overall Rank
GOVX Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
GOVX Sortino Ratio Rank: 44
Sortino Ratio Rank
GOVX Omega Ratio Rank: 44
Omega Ratio Rank
GOVX Calmar Ratio Rank: 22
Calmar Ratio Rank
GOVX Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for GeoVax Labs, Inc. (GOVX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GOVXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.66

Sortino ratioReturn per unit of downside risk

-4.59

Omega ratioGain probability vs. loss probability

0.77

1.37

-0.60

Calmar ratioReturn relative to maximum drawdown

-0.99

2.78

-3.77

Martin ratioReturn relative to average drawdown

-1.35

12.44

-13.78

Dividends

Dividend History


GeoVax Labs, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the GeoVax Labs, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the GeoVax Labs, Inc. was 100.00%, occurring on Apr 29, 2026. The portfolio has not yet recovered.

The current GeoVax Labs, Inc. drawdown is 100.00%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-100.00%Apr 2026
6y 11mo
7y 1moMay 2019 - now
2019 bear market2019
-99.16%May 2019
6y 7mo1d
6y 7moSep 2012 - May 2019
2012 correction2012
-10.11%Aug 2012
10d10d
20dJul 2012 - Aug 2012
2012 pullback2012
-5.26%Aug 2012
1d9d
10dAug 2012 - Aug 2012
2012 pullback2012
-4.21%Aug 2012
4d10d
14dAug 2012 - Sep 2012

Drawdown Indicators


GOVXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-56.78%

-43.22%

Max Drawdown (1Y)

Largest decline over 1 year

-95.62%

-9.10%

-86.52%

Max Drawdown (3Y)

Largest decline over 3 years

-99.55%

-18.90%

-80.65%

Max Drawdown (5Y)

Largest decline over 5 years

-99.95%

-25.43%

-74.52%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

-33.92%

-66.08%

Current Drawdown

Current decline from peak

-100.00%

-1.80%

-98.20%

Average Drawdown

Average peak-to-trough decline

-88.03%

-10.71%

-77.32%

Ulcer Index

Depth and duration of drawdowns from previous peaks

70.10%

2.03%

+68.07%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of GeoVax Labs, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how GeoVax Labs, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for GOVX relative to other companies in the Biotechnology industry. Currently, GOVX has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with GOVX

Add GeoVax Labs, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with GOVX